Japan Pharma Earnings Show SGLT-2 Market Uptake Still Slow

May 22, 2017
By Reiji Anasako With Japan’s full-year financial reporting season coming to a close, Jiho looked into how competition is changing the market structure in the diabetes arena in the country, which became the second largest market after oncology in FY2016...read more